Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|May 15, 2015
The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies: author's replyAnna Flammiger, Mascha Binder
Immunity|May 14, 2025
nACh receptors engage a nice ChAT with the liver: B cells serving up regenerationChristoph Schultheiß, Mascha Binder
Signal Transduction and Targeted Therapy|August 9, 2022
Curse and blessing: upregulation of oncogenes upon treatment with hypomethylating agents in myelodysplastic syndromeJuliane Grimm, Mascha Binder
Annals of Translational Medicine|November 22, 2016
Modifying therapy in patients with advanced Hodgkin's lymphoma by integrating early metabolic response by interim PET-CTUlrike Bacher, Mascha Binder
Signal Transduction and Targeted Therapy|March 4, 2022
Overcoming unintended immunogenicity in immunocompetent mouse models of metastasis: the case of GFPChristoph Schultheiß, Mascha Binder
Leukemia Research|January 28, 2014
The role of CD81 for plasma cell dyscrasiasMascha Binder, Ulrike Bacher
Leukemia Research|September 20, 2011
Identification of genetic parameters associated with disease progression in plasma cell myelomaUlrike Bacher, Mascha Binder
Current Oncology (Toronto, Ont.)|March 24, 2022
Circulating Tumor DNA in Gastric and Gastroesophageal Junction CancerLisa Paschold, Mascha Binder
Expert Opinion on Drug Discovery|March 16, 2013
Drugs targeting integrins for cancer therapyMascha Binder, Martin Trepel
Translational Cancer Research|February 12, 2026
Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancerTobias Andermatt, Christoph Schultheiss, Mascha Binder
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|May 15, 2015
The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies: author's replyAnna Flammiger, Mascha Binder
Immunity|May 14, 2025
nACh receptors engage a nice ChAT with the liver: B cells serving up regenerationChristoph Schultheiß, Mascha Binder
Signal Transduction and Targeted Therapy|August 9, 2022
Curse and blessing: upregulation of oncogenes upon treatment with hypomethylating agents in myelodysplastic syndromeJuliane Grimm, Mascha Binder
Annals of Translational Medicine|November 22, 2016
Modifying therapy in patients with advanced Hodgkin's lymphoma by integrating early metabolic response by interim PET-CTUlrike Bacher, Mascha Binder
Signal Transduction and Targeted Therapy|March 4, 2022
Overcoming unintended immunogenicity in immunocompetent mouse models of metastasis: the case of GFPChristoph Schultheiß, Mascha Binder
Leukemia Research|January 28, 2014
The role of CD81 for plasma cell dyscrasiasMascha Binder, Ulrike Bacher
Leukemia Research|September 20, 2011
Identification of genetic parameters associated with disease progression in plasma cell myelomaUlrike Bacher, Mascha Binder
Current Oncology (Toronto, Ont.)|March 24, 2022
Circulating Tumor DNA in Gastric and Gastroesophageal Junction CancerLisa Paschold, Mascha Binder
Expert Opinion on Drug Discovery|March 16, 2013
Drugs targeting integrins for cancer therapyMascha Binder, Martin Trepel
Translational Cancer Research|February 12, 2026
Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancerTobias Andermatt, Christoph Schultheiss, Mascha Binder
Pageof 17